BURKHARD BLANK

CIK 1073409 · EVP Chief Medical Officer · last filed 2025-07-17

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.69M

Companies

3

Total Filings

25

Lifetime Open-Market Net

-$1.33M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
MNKD EVP Chief Medical Officer 460,791 $3.66 $1.69M $0 7 2025-07-17
Acorda Therapeutics, Inc. (ACOR) Delisted CMO and Head of R&D 18,527 $0.66 $12.2K -$1.33M 14 2021-03-05
Altus Pharmaceuticals Inc. (ALTU) Delisted EVP & Chief Medical Officer $10.12 $0 4 2008-05-27

Recent Filings · Page 3 of 3

25 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-07-06 Acorda Therapeutics, Inc. (ACOR) Delisted Grant (A) +50,000 $0 EDGAR
2008-05-27 Altus Pharmaceuticals Inc. (ALTU) Delisted Grant (A) $0 EDGAR
2008-02-27 Altus Pharmaceuticals Inc. (ALTU) Delisted Grant (A) $0 EDGAR
2008-01-11 Altus Pharmaceuticals Inc. (ALTU) Delisted Grant (A) $0 EDGAR
2007-03-06 Altus Pharmaceuticals Inc. (ALTU) Delisted Grant (A) $0 EDGAR
Showing 2125 of 25
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.